Naoto T Ueno, MD, PhD@teamoncology
Nasty looking clouds over Houston area. @united https://pic.twitter.com/YiXLLbimCD
posted at 03:23:54
| Stats | Twitter歴 3,814日（2009/04/14より） |
ツイート数 69,495（18.2件/日） |
表示するツイート :
2019年09月22日(日)2 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
A real issue, which harms US healthcare & medical research. Med students avoid discipline with long-hours and lower salary disciplines or research because of the debt. The reason why emergency medicine, anesthesiology, dermatology, and radiology are popular. https://twitter.com/NYTHealth/status/1175453007292653568…
posted at 03:13:21
2019年09月21日(土)5 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
.@united hub @NRT. A great Asian hub. Well connected with @FlyANA_official https://pic.twitter.com/bZqEp41JUU
posted at 16:22:53
Naoto T Ueno, MD, PhD@teamoncology
Japan's Empress Emerita Michiko has breast cancer completely removed | The Japan Times The best scenario as #breastcancer to have luminal A stage I. Happy for your Highness. If she was younger, she would need genomic testing. https://www.japantimes.co.jp/news/2019/09/20/national/japans-empress-emerita-michiko-breast-cancer-completely-removed/…
posted at 16:17:37
Naoto T Ueno, MD, PhD@teamoncology
MD安徳森癌症中心, Chinese
MDアンダーソンがんセンター, Japanese
MD Anderson Cancer Center, English
Онкологический центр имени МД Андерсона, Russian #endcancer
posted at 15:03:49
Naoto T Ueno, MD, PhD@teamoncology
#PLOSONE: Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer ... http://dx.plos.org/10.1371/journal.pone.0222336…
posted at 14:45:23
Naoto T Ueno, MD, PhD@teamoncology
Perspective of cancer experience continue to change as time lapses. I learned that I will self protect myself by erasing some of the negative experiences or converting the negative to a positive experience. What a powerful defense mechanism that humans have. #endcancer
posted at 13:39:06
2019年09月20日(金)11 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Success of nearly half of European cancer drug trials 'exaggerated' due to bias: a very concerning report. https://www.fiercebiotech.com/cro/success-nearly-half-european-cancer-drug-trials-exaggerated-due-to-bias-report…
posted at 18:23:44
Naoto T Ueno, MD, PhD@teamoncology
@isolabella666 Thanks!!!
posted at 17:55:24
Naoto T Ueno, MD, PhD@teamoncology
A great review. I noticed myself adopting all of the technologies in the development of functional preclincial team. Still, it will take time to adapt this for a meaningful clinical translation. https://twitter.com/jsoriamd/status/1174673907481272320…
posted at 17:51:41
Naoto T Ueno, MD, PhD@teamoncology
日本のゲノム医療はインフラ整備状況であり、平均的な患者の希望になり得る状況では無い。真摯に今の状況を世に発信すべきであり、マスコミと一部の医師の欧米追随型のハイプはやめてください。
posted at 16:19:17
Naoto T Ueno, MD, PhD@teamoncology
36 foods that can help lower your cancer risk | from MD Anderson Cancer Center @MDAndersonNews #endcancer https://www.mdanderson.org/publications/focused-on-health/36-foods-that-can-help-lower-your-cancer-risk.h12-1592991.html…
posted at 14:28:05
Naoto T Ueno, MD, PhD@teamoncology
がんのリスクを低減するための食品36選、MDアンダーソンがんセンターの翻訳記事 https://www.cancerit.jp/62710.html
posted at 14:26:45
Naoto T Ueno, MD, PhD@teamoncology
医者であってもがんになったからそころの患者と何にも変わりません。動揺しにくいと聞くと強がりではないかと思ってしまう。 https://twitter.com/isolabella666/status/1173926181025898497…
posted at 14:22:44
Naoto T Ueno, MD, PhD@teamoncology
Tried all the local yummies at Xiamen. Satisfied my taste buds. https://pic.twitter.com/LkPepdZihE
posted at 14:22:43
Naoto T Ueno, MD, PhD@teamoncology
A beautiful Xiamen. https://pic.twitter.com/zqe7ZuKVmz
posted at 14:17:29
Naoto T Ueno, MD, PhD@teamoncology
MD安徳森癌症中心, Chinese
MDアンダーソンがんセンター, Japanese
MD Anderson Cancer Center, English
Let me know how you write MDA in your language. #endcancer @MDAndersonNews
posted at 14:06:13
Naoto T Ueno, MD, PhD@teamoncology
My week on Twitter 🎉: 9 Mentions, 677 Likes, 101 Retweets, 214K Retweet Reach, 26 New Followers. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/KM95mqgaGk
posted at 10:00:23
2019年09月19日(木)4 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Our biggest fans this week: itoshunya, lalahearttwit, caseofdees. Thank you! via https://sumall.com/thankyou?utm_source=twitter&utm_medium=publishing&utm_campaign=thank_you_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/wyeeAgutiT
posted at 23:02:23
Naoto T Ueno, MD, PhD@teamoncology
Medical Tribune China Interview with Dr Xiaojia Wang from Zhenjiang Cancer Hospital. Discussed about the best standard of care for triple negative breast cancer and our Moonshot effort at MD Anderson Cancer Center. #endcancer https://pic.twitter.com/wRduQ17Ci5
posted at 18:22:19
Naoto T Ueno, MD, PhD@teamoncology
Attending the largest oncology meeting CSCO at Xiamen. 廈門で中国で最大の臨床がん学会に出席しています。 https://pic.twitter.com/glRqvyMXBO
posted at 18:21:06
Naoto T Ueno, MD, PhD@teamoncology
Perfumeのベストアルバムは今回で２回目。前回のベストアルバムが出た時はもしや解散するのではないかと不安になった。今回は15年間と言う大きな奇跡を起こしてくれたパフュームに感激。14年近くファンであってよかった。「Perfume The Best “P Cubed”」 https://youtu.be/Zv28IP4Z2jY ##prfmmed #prfm
posted at 15:01:52
2019年09月17日(火)4 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
本日到着。幸福なり。この大きさに驚き。パフュームの集大成。10何年ファンであってよかった。コングラチュレーション。Finally I got the perfume the best. Glad that being a fan for more than 10 years. Congratulations. #prfm #prfmmed https://pic.twitter.com/1U371155kE
posted at 15:11:00
Naoto T Ueno, MD, PhD@teamoncology
Glad to see my friend @PatrickNewell who is the founder of @TEDxTokyo at Meiji Shrine. Always he is very inspirational and helps me to put my thought together of how to create a Cancer So What Society. https://pic.twitter.com/xuEEoVnriD
posted at 09:59:28
Naoto T Ueno, MD, PhD@teamoncology
Calmness in early morning at Meiji Shrine. https://pic.twitter.com/2NCbc0znTZ
posted at 07:50:23
Naoto T Ueno, MD, PhD@teamoncology
FDA: All CDK4/6 inhibitors Linked to Severe Lung Illness (pneumonitis) https://www.medpagetoday.com/hematologyoncology/breastcancer/82165… #bcsm
posted at 04:30:01
2019年09月16日(月)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
My friends from CancerX. CancerX の素敵な仲間 #CancerX2020 https://pic.twitter.com/AI69aWCtud
posted at 19:58:23
Naoto T Ueno, MD, PhD@teamoncology
いよいよ本格的にCancerX Summit 2020の準備がはじまります。Exciting!! 来年2/2が開催日。 https://pic.twitter.com/N5tg8UACCo
posted at 18:17:13
Naoto T Ueno, MD, PhD@teamoncology
2020 CancerX Summit volunteer open recruitment session will start soon!! 多数の出席有難うございます！ https://pic.twitter.com/ggjW0j44GW
posted at 18:13:52
2019年09月15日(日)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
One of the best workshops for learning how to manage cancer treatment-related side effect when there is no high-level evidence. Why do we not have this kind of workshop in the USA? https://pic.twitter.com/GE4fZNWTXx
posted at 09:05:33
2019年09月14日(土)3 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Rash induced by immunotherapy. If you see a two color target appearance changes. Need to worry. Need biopsy and ask for dermatologist help.
posted at 15:06:37
Naoto T Ueno, MD, PhD@teamoncology
Taxane cause three types of skin changes. Facial redness, dermatitis, and nail changes.
posted at 15:04:30
Naoto T Ueno, MD, PhD@teamoncology
Constipation is a major issue among cancer patients. Prevention of constipation is the best. It can reduce performance status.
posted at 13:50:55
2019年09月13日(金)6 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Happy Birthday! The first hospital that I served as a physician. https://twitter.com/usnhyokosuka/status/1172411079244181504…
posted at 21:07:29
Naoto T Ueno, MD, PhD@teamoncology
My week on Twitter 🎉: 2 Mentions, 215 Mention Reach, 11 Likes, 5 Retweets, 6.01K Retweet Reach. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/RMMibINq8M
posted at 10:00:24
Naoto T Ueno, MD, PhD@teamoncology
If FDA approves pembrolizumab in the neoadjuvant setting for TNBC, it is a game-changer for how we develop treatment for TN metastatic breast cancer at the time of recurrence. Preclinical models for drug development is all immunotherapy naive disease model. :( #bcsm @OncoAlert
posted at 04:15:38
Naoto T Ueno, MD, PhD@teamoncology
Positive data of immunotherapy in neoadjuvant chemotherapy setting for TNBC is a game changer. The question is whether this is only for PDL1 positive only. And how impactful is the immunotherapy to pCR rate. #bcsm @OncoAlert
posted at 04:09:53
Naoto T Ueno, MD, PhD@teamoncology
I am excited to learn more about the new immunotherapy data for #Breastcancer @myESMO meeting in late Sept. #bcsm
posted at 04:06:02
Naoto T Ueno, MD, PhD@teamoncology
A metastatic breast cancer with a very poor performance status (condition). The best treatment is not to treat. Patient lived well without suffering any further. Hard to understand for some patients but my goal is not to provide suffering from my practice. #OncoAlert
posted at 03:00:43
2019年09月12日(木)6 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
Our biggest fans this week: MDAndersonLib, BisratDebeb, lifeafterlola. Thank you! via https://sumall.com/thankyou?utm_source=twitter&utm_medium=publishing&utm_campaign=thank_you_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/aiAGesWUJ2
posted at 23:03:35
Naoto T Ueno, MD, PhD@teamoncology
New Mexico! https://pic.twitter.com/sASWDXfkrh
posted at 15:10:38
Naoto T Ueno, MD, PhD@teamoncology
@BADammann @InflammatoryBCa @MDAndersonNews Thanks!! Please spread the video.
posted at 15:09:08
Naoto T Ueno, MD, PhD@teamoncology
誰が入閣したを報道するのは当然だが、ポストの仕事内容を理解しないで、人物像に騒ぐのは愚かなり。
posted at 15:08:10
Naoto T Ueno, MD, PhD@teamoncology
乳がんにはシコリを触れない乳がんがある。またマンモグラフィーに映らない乳がんもある。赤く腫れた乳房を見れば炎症性乳がんを疑う常識を持って欲しい。多くは感染だが乳がんを見逃すと痛い目に合う。
posted at 15:05:53
Naoto T Ueno, MD, PhD@teamoncology
「手かざし」に頼る池江璃花子に「治療の遅れ」心配する声. これ事実なら新たなる詐欺です。手かざしはがんには効きません。 https://www.news-postseven.com/archives/20190910_1449762.html…
posted at 07:42:56
2019年09月08日(日)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Watch our new video about Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. Exciting video why we have an IBC clinic. @InflammatoryBCa @MDAndersonNews https://youtu.be/OrMAQe1S3ks #endcancer
posted at 01:03:21
2019年09月06日(金)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
My week on Twitter 🎉: 60 Likes, 16 Retweets, 24K Retweet Reach. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/arH1oISGmH
posted at 10:00:37
2019年09月05日(木)1 tweetsource
Naoto T Ueno, MD, PhD@teamoncology
Our biggest fans this week: OncoAlert, IBCradiation, BisratDebeb. Thank you! via https://sumall.com/thankyou?utm_source=twitter&utm_medium=publishing&utm_campaign=thank_you_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/X8P0jRhumn
posted at 23:03:39
2019年08月30日(金)4 tweetssource
Naoto T Ueno, MD, PhD@teamoncology
7th International Inflammatory Breast Cancer Conference will take place just before the #SABCS20 in Texas. Hope that you can join this exciting meeting. #endcancer @MDAndersonNews @InflammatoryBCa will host the conference.
posted at 22:32:28
Naoto T Ueno, MD, PhD@teamoncology
まともな医師はがんが消えるとは言わないです。がんが消えるという表現あるいは患者の証言を前面に出している情報あるいは記事は大抵詐欺ですので御注意を。
posted at 22:28:17
Naoto T Ueno, MD, PhD@teamoncology
My week on Twitter 🎉: 2 Mentions, 4.33K Mention Reach, 32 Likes, 2 Retweets, 834 Retweet Reach. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/C51Or0QlMa
posted at 10:00:25
Naoto T Ueno, MD, PhD@teamoncology
Japan reports of improving the vision by iPS cornea trasnplant. An incredible report. So far no rejection. Another step to regenerating organs or tissues by iPS. https://news.tbs.co.jp/newseye/tbs_newseye3763709.html…
posted at 00:01:48
